- Home
- SMTI vs OCGN Comparison
SMTI vs OCGN Comparison
Compare SMTI & OCGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMTI
- OCGN
- Stock Information
- Founded
- SMTI 1982
- OCGN 2013
- Country
- SMTI United States
- OCGN United States
- Employees
- SMTI N/A
- OCGN N/A
- Industry
- SMTI Medical/Dental Instruments
- OCGN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SMTI Health Care
- OCGN Health Care
- Exchange
- SMTI Nasdaq
- OCGN Nasdaq
- Market Cap
- SMTI 288.2M
- OCGN 338.2M
- IPO Year
- SMTI N/A
- OCGN N/A
- Fundamental
- Price
- SMTI $34.39
- OCGN $1.03
- Analyst Decision
- SMTI Buy
- OCGN Strong Buy
- Analyst Count
- SMTI 1
- OCGN 3
- Target Price
- SMTI $44.00
- OCGN $5.33
- AVG Volume (30 Days)
- SMTI 24.7K
- OCGN 3.2M
- Earning Date
- SMTI 11-12-2024
- OCGN 11-08-2024
- Dividend Yield
- SMTI N/A
- OCGN N/A
- EPS Growth
- SMTI N/A
- OCGN N/A
- EPS
- SMTI N/A
- OCGN N/A
- Revenue
- SMTI $72,410,222.00
- OCGN $7,263,000.00
- Revenue This Year
- SMTI $26.97
- OCGN N/A
- Revenue Next Year
- SMTI $18.91
- OCGN N/A
- P/E Ratio
- SMTI N/A
- OCGN N/A
- Revenue Growth
- SMTI 21.42
- OCGN 112.62
- 52 Week Low
- SMTI $26.00
- OCGN $0.35
- 52 Week High
- SMTI $43.25
- OCGN $2.11
- Technical
- Relative Strength Index (RSI)
- SMTI 64.02
- OCGN 61.69
- Support Level
- SMTI $32.91
- OCGN $0.91
- Resistance Level
- SMTI $34.03
- OCGN $0.98
- Average True Range (ATR)
- SMTI 1.39
- OCGN 0.07
- MACD
- SMTI 0.24
- OCGN 0.02
- Stochastic Oscillator
- SMTI 100.00
- OCGN 83.33
About SMTI Sanara MedTech Inc.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are HYCOL Hydrolyzed Collagen, BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.
About OCGN Ocugen Inc.
Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").